Want to see NL:OCI full AI Analyst Report?
Top Page
OCI N.V.
(OCI)
Select Model
Select Model
Rating:50Neutral
Price Target:
€4.00
▲(5.82% Upside)
Action:Reiterated
Date:06/26/26
The score is held down primarily by weak and volatile fundamentals, especially the recent deterioration in operating results and cash flow. Technical indicators are a positive offset, with price above key moving averages and a positive MACD, but the overbought RSI reduces conviction. Valuation is difficult to support with a negative P/E and an unusually high dividend yield that may signal sustainability risk.
Positive Factors
Deleveraging / Balance Sheet Health
Material debt reduction has lowered financial risk and improved flexibility. Over a 2-6 month horizon this provides enduring buffer against cyclical earnings, supports access to capital or refinancing on better terms, and gives management scope to prioritize operations or selective investment rather than emergency liability management.
Negative Factors
Volatile revenue and earnings
Persistent volatility in revenue and recurrent swings between large profits and losses indicate limited pricing power and exposure to commodity cycles. Over months this undermines forecasting, reduces margin sustainability, complicates capital allocation, and raises execution risk for strategic initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraging / Balance Sheet Health
Material debt reduction has lowered financial risk and improved flexibility. Over a 2-6 month horizon this provides enduring buffer against cyclical earnings, supports access to capital or refinancing on better terms, and gives management scope to prioritize operations or selective investment rather than emergency liability management.
Read all positive factors
OCI N.V. (OCI) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€858.78M
Dividend Yield229.25%
Average Volume (3M)974.70K
Price to Earnings (P/E)―
Beta (1Y)0.68
Revenue GrowthN/A
EPS GrowthN/A
CountryNL
Employees761
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-1.62
Shares Outstanding211,357,990
10 Day Avg. Volume721,335
30 Day Avg. Volume974,704
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.73
Price to Sales (P/S)0.72
P/FCF Ratio-3.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.10Price Target Upside8.47% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.07
Revenue Forecast (FY)€1.11B
OCI N.V. Business Overview & Revenue Model
Company Description
OCI N.V. operates as an international producer and supplier of natural gas-derived products and industrial chemicals, catering to customers across the agricultural, transportation, and manufacturing industries. The company's activities are organiz...
How the Company Makes Money
OCI makes money primarily by producing and selling commodity chemical products, with revenue largely driven by volumes sold and prevailing market prices for nitrogen-based products. Key revenue streams include: (1) Sales of nitrogen fertilizers (e...
OCI N.V. Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
56
Neutral
Cash Flow
34
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.09B | 975.10M | 1.96B | 3.71B | 6.32B |
| Gross Profit | 23.70M | 2.00M | -164.60M | 435.00M | 1.83B |
| EBITDA | -205.20M | 38.90M | -144.00M | 565.30M | 2.47B |
| Net Income | 183.70M | 4.98B | -392.00M | 1.24B | 570.50M |
Balance Sheet | |||||
| Total Assets | 1.84B | 4.33B | 8.97B | 9.77B | 9.81B |
| Cash, Cash Equivalents and Short-Term Investments | 17.90M | 2.05B | 156.90M | 1.69B | 1.44B |
| Total Debt | 155.30M | 803.70M | 2.30B | 3.15B | 4.08B |
| Total Liabilities | 764.60M | 2.08B | 7.02B | 5.43B | 6.30B |
| Stockholders Equity | 1.07B | 2.24B | 926.50M | 2.32B | 2.00B |
Cash Flow | |||||
| Free Cash Flow | -202.40M | -8.20M | 530.80M | 2.95B | 2.02B |
| Operating Cash Flow | -82.20M | 68.10M | 695.30M | 3.35B | 2.26B |
| Investing Cash Flow | 517.57M | 8.07B | -774.30M | -390.80M | -243.50M |
| Financing Cash Flow | -2.51B | -6.13B | -818.20M | -2.44B | -1.50B |
OCI N.V. Technical Analysis
Positive
3.78
Price Trends
3.82
Positive
3.68
Positive
3.52
Positive
Market Momentum
0.09
Positive
70.24
Negative
73.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:OCI, the sentiment is Positive. The current price of 3.78 is below the 20-day moving average (MA) of 3.98, below the 50-day MA of 3.82, and above the 200-day MA of 3.52, indicating a bullish trend. The MACD of 0.09 indicates Positive momentum. The RSI at 70.24 is Negative, neither overbought nor oversold. The STOCH value of 73.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:OCI.
OCI N.V. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | €5.44B | 23.90 | 10.83% | 2.83% | 1.08% | -24.24% | |
62 Neutral | €9.86B | 15.82 | 14.61% | 3.38% | -7.05% | 32.41% | |
59 Neutral | €1.20B | 15.88 | 8.84% | 3.50% | -1.61% | 38.58% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | €3.38B | 113.34 | -0.24% | 5.41% | -4.14% | -87.08% | |
53 Neutral | €994.54M | -86.87 | 6.84% | 1.46% | 11.26% | 11.66% | |
50 Neutral | €858.78M | -2.88 | ― | 229.25% | ― | ― |
* General Sector Average
NL:OCI
OCI N.V.
4.08
-0.60
-12.84%
NL:AKZA
Akzo Nobel NV
57.58
0.42
0.74%
NL:AMG
AMG ADVANCED METALLURGICAL GROUP NV
29.60
4.45
17.67%
NL:APAM
Aperam S.A.
46.64
20.91
81.24%
NL:CRBN
Corbion NV
20.48
3.20
18.54%
NL:IMCD
IMCD N.V.
88.20
-22.22
-20.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.